Tour de France race director Christian Prudhomme has backed the UCI investigation into Chris Froome and hopes the four-time yellow jersey winner's case is resolved quickly.
In December, Froome was asked to explain elevated levels of salbutamol in a urine sample taken during the Vuelta a Espana – a race Froome won.
Asthma medication salbutamol is permitted by WADA rules without the need for a therapeutic use exemption (TUE) when inhaled up to a limit of 1,600 micrograms over 24 hours.
The adverse finding, confirmed through a test of the 32-year-old's sample, does not necessarily constitute a break of the rules and Froome has not been handed a provisional suspension.
Froome remains adamant he has not done anything wrong and insisted that he did not exceed the permitted dosage – despite having twice the legal limit in his system.
His Vuelta win was added to a palmares that includes four Tour titles, with Froome using his position at the top of the sport to encourage clean riding.
Prudhomme was reluctant to discuss the Briton's case on Tuesday as the route for the 2018 Paris-Nice event was announced, but hopes it is all resolved soon so attention can turn back to the new World Tour season.
"I'm not going to say lots about Chris Froome today but I'll just say this: we wish for an outcome as quickly as possible," he said.
"The investigation will be no doubt led in a strong way with the new International Cycling Union president David Lappartient, that's what we want, we need to come out of this obscurity, come out of this ambiguity and we want this to happen as quickly as possible."